DIDS inhibits overexpression BAK1-induced mitochondrial apoptosis through GSK3β/β-catenin signaling pathway

Xiayun Yang1, Shusheng Tang1, Daowen Li1

  • 1Department of Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, Haidian District, China.

Insights

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) prevents cell death induced by Bcl-2 homologous antagonist/killer (BAK1) overexpression. DIDS protects against BAK1-induced apoptosis by modulating the GSK3β/β-catenin signaling pathway.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Bcl-2 homologous antagonist/killer (BAK1) is a key regulator of mitochondrial apoptosis.
  • The precise molecular mechanisms underlying BAK1-induced apoptosis are not fully understood.
  • 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) is known to protect cells from apoptosis.

Purpose of the Study:

  • To investigate whether DIDS can inhibit BAK1-induced mitochondrial apoptosis.
  • To explore the role of the GSK3β/β-catenin signaling pathway in DIDS's protective effect.

Main Methods:

  • Overexpression of BAK1 in 293T cells.
  • Analysis of apoptosis markers (cleaved caspase-9, -3, PARP) and mitochondrial membrane potential (MMP).
  • Assessment of GSK3β and β-catenin expression levels.
  • Treatment with DIDS and lithium chloride (LiCl).

Main Results:

  • BAK1 overexpression induced mitochondrial apoptosis, increasing cleaved caspase-9, -3, PARP, and decreasing MMP.
  • BAK1 overexpression reduced Ser9-GSK3β and β-catenin levels.
  • LiCl attenuated BAK1-induced apoptosis by restoring Ser9-GSK3β and β-catenin.
  • DIDS completely blocked BAK1-induced apoptosis by restoring Ser9-GSK3β and β-catenin.

Conclusions:

  • DIDS inhibits BAK1-induced mitochondrial apoptosis.
  • The protective mechanism of DIDS involves the GSK3β/β-catenin signaling pathway.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K